Hepatology
27 articles · 1 journals
Journals in this subcategory (1)
- iLIVER · Elsevier (27)
- Research progress on hepatitis B surface antigen decline and clearance
- Regulatory roles and translational potential of the Kruppel-like factor family in liver disease
- Scorpion venom peptides: Novel therapeutic approaches for inflammatory and hepatic disorders
- Understanding the role of hypoxia inducible factors in liver fibrosis and future therapeutic applications
- Global trends, health inequalities, and long-term projections concerning liver cancer mortality attributable to nonalcoholic steatohepatitis between 1990 and 2050
- The impact of blood ammonia after interventional therapy on the prognosis of patients with unresectable hepatocellular carcinoma
- Comparison of surgical treatment versus transcatheter arterial chemoembolization combined with systemic treatment for spontaneously ruptured hepatocellular carcinoma
- Functional vulnerability and all-cause mortality among community-dwelling United States adults with a history of hepatitis or chronic liver disease
- Secondary analysis of California regional water boards dataset: Morphological distribution of aquatic microplastics in San Francisco Bay and implications for liver disease pathogenesis
- Salvage robotic associating liver partition and portal vein ligation for staged hepatectomy for advanced hepatocellular carcinoma with insufficient future liver remnant after conversion therapy
- Burden of metabolic dysfunction-associated fatty liver disease in people ≥70 years of age in Chinese Mainland, USA, and European Union during 2012–2023
- Short-term outcomes of entecavir versus tenofovir treatment for HBV-associated acute-on-chronic liver failure: a retrospective cohort study
- Advancing the clinical utility of prognostic artificial intelligence in hepatocellular carcinoma
- The staging of perihilar cholangiocarcinoma: From anatomy to biology, condition, and beyond
- Conversion therapy for hepatocellular carcinoma: paradigm shifts, unresolved controversies, and translational horizons
- Sequential surgery after conversion therapy for advanced hepatocellular carcinoma: Evidence, controversies, and perspectives
- Spatial immune remodeling during neoadjuvant therapy in hepatocellular carcinoma: Mechanisms, clinical implications, and future perspectives
- Clinical significance of RNA modifications in hepatic fibrosis
- Preoperative MRI-derived fat fraction is linked to survival after liver transplantation for hepatocellular carcinoma
- A cohort study on efficacy and safety of treatment modalities for resectable hepatocellular carcinoma with extrahepatic metastasis
- Thyroid-stimulating hormone–body mass index profile and mortality in metabolic dysfunction-associated steatotic liver disease
- The SASP-associated long noncoding RNA NEAT1 modulates the tumor immune microenvironment in hepatocellular carcinoma
- LILRB4 expression is associated with macrophage enrichment and differential survival in hepatocellular carcinoma
- Single-cell profiling reveals GABBR1 as a cuproptosis-regulated prognostic biomarker in pancreatic cancer
- Rewiring the neural niche: Prostaglandin E2 promotes Schwann cell–mediated perineural invasion in pancreatic cancer
- Intraductal oncocytic papillary neoplasm of the pancreas: A case report and literature review
- Erratum to “Regulatory roles and translational potential of the Kruppel-like factor family in liver disease” [iLIVER 5 (2026) 100252]